The CARILLON Mitral Contour System combines a proprietary implantable device and delivery system. The implant consists of a shaping ribbon between distal and proximal anchors.
The device is delivered percutaneously via jugular access under fluoroscopic guidance in a minimally invasive or non-surgical procedure called Percutaneous Mitral Annuloplasty. The implant is designed to be positioned, adjusted, and gently anchored in the coronary sinus/great cardiac vein to reshape the annulus around the mitral valve to reduce mitral regurgitation.
Cardiac Dimensions®, Inc. has obtained early clinical experience with a previous design of the CARILLON Implant. These studies were conducted in Europe, Paraguay, and Australia. To date, more than 50 people have been treated with the permanent implant. Preclinical and early clinical data have suggested both a reduction in mitral regurgitation in some patients, as well as, improvements along other key parameters including NYHA class, 6 Minute Walk distance, and Quality of Life.
Cardiac Dimensions®, Inc. has obtained early clinical experience with a previous design of the CARILLON Implant. These studies were conducted in Europe, Paraguay, and Australia. To date, more than 50 people have been treated with the permanent implant. Preclinical and early clinical data have suggested both a reduction in mitral regurgitation in some patients, as well as, improvements along other key parameters including NYHA class, 6 Minute Walk distance, and Quality of Life.
In this non-surgical procedure, a catheter is threaded into the heart via the jugular vein.
The catheter is guided to a vein that encircles the mitral valve.
The CARILLON™ Implant is secured and released in the treatment location
The CARILLON™ Implant is designed to:
• Reshape the valvular dimensions
• Tighten the valve leaflets
• Reduce mitral regurgitation